Company Information
USD
2.55
- (4.5%)
NASDAQ:MYNZ, MAINZ BIOMED NV
Industry: Diagnostics & Research
End of Day: 8 May 2025 GMT-4
Mainz Biomed NV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. Its main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.
Address
Robert Koch Strasse 5
Sirius Gutenberg Park
Website
Classification
Sector
Healthcare
Industry Group
Medical Diagnostics & Research
Industry
Diagnostics & Research
Key Executives
Dr. Heiner Dreismann,PhD
Director
Mr. Gregory J. Tibbitts
Director
Mr. William J. Caragol
CFO
Mr. Darin Leigh
Other Executive Officer
Mr. Guido Baechler
CEO/Director
Dr. Moritz Eidens
Chief Scientific Officer/Director
Dr. Alberto Libanori, PhD
Director
Mr. Hans Hekland
Director
Mr. Philipp Freese
COO
Mr. Nicole Holden
Director
Ownership
Institution Holdings
Fidelity Management & Research Company LLC
15,189 (0.075%)
Make Smart Investment Choices